MRNA
Moderna, Inc.
Stock
$190.01+1.07 (+0.57%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $483M
- YoY, 2025
- +12.6%
- 5-year CAGR
- +39.0%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $483M | +12.6% |
| 2024 | $429M | +40.7% |
| 2023 | $305M | +35.0% |
| 2022 | $226M | +59.2% |
| 2021 | $142M | +52.7% |
| 2020 | $93M | +14.8% |
| 2019 | $81M | +11.6% |
| 2018 | $73M | +81.2% |
| 2017 | $40M | +1.8% |
| 2016 | $39M | — |